Features - Pharmaceutical Technology

Drug delivery innovations push forth women’s health

Manasi Vaidya — Thu, 11 Apr 2024 07:00:00 +0000

From nanoparticles to transdermal patches, Pharmaceutical Technology takes a look at the latest in drug delivery technologies for women's health.

Harnessing pharmacovigilance to turn reactive investigation into active discovery

Natasha Spencer-Jolliffe — Thu, 04 Apr 2024 08:00:00 +0000

Using real-world data, proactive signal detection may have a transformative effect on pharma’s ability to efficiently report adverse events.

Continuous monitoring expands aseptic knowledge and data in real time

Natasha Spencer-Jolliffe — Wed, 03 Apr 2024 10:47:30 +0000

Real-time monitoring in cleanrooms can provide a more comprehensive overview of aseptic processing sessions.

Can pharma overcome generative AI’s bias problem?

Natasha Spencer-Jolliffe — Tue, 02 Apr 2024 12:30:19 +0000

While the use of generative AI to optimise the practitioner-to-patient relationship grows, ethical questions over bias thwart pharma’s reliance on the tech.

Magazine: What’s next for AAV gene therapies in 2024?

Manasi Vaidya — Tue, 02 Apr 2024 07:00:00 +0000

In this issue: High-profile gene therapies that use AAV vectors, new research into HIV-TB coinfection treatments, traceability technologies for the supply chain, and more.

The top emerging pharmaceutical companies in the US

Irena Maragkou — Tue, 26 Mar 2024 11:20:34 +0000

Molecular glues are the latest craze in pharma research, but what are they?

Isaac Hanson — Thu, 21 Mar 2024 15:53:16 +0000

Deals involving research into molecular glues have skyrocketed this year as big pharma bets on their revolutionary potential.

Donanemab: FDA AdCom will put spotlight on tau enrolment and ARIA concerns

Abigail Beaney — Thu, 21 Mar 2024 10:15:59 +0000

Lilly says that the FDA wants to look closer at efficacy implications of the Phase III donanemab trial design before giving the green light.

Magazine: Biotechs surf obesity drug wave to go beyond GLP-1RAs

Manasi Vaidya — Wed, 20 Mar 2024 13:00:29 +0000

In this issue: Studying novel obesity drugs, pharma prepares for climate disasters, the CRISPR pipeline accelerates, and more.

Is HIV-TB coinfection treatment entering a new frontier?

Natasha Spencer-Jolliffe — Wed, 20 Mar 2024 07:00:00 +0000

TB is the leading determiner of death in patients with HIV, yet while new drug research is underway, funding and accessible treatments remain distant.